Benjamini O, Jain P, Trinh L, et al. Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes. Leuk Lymphoma. 2015;56(6):1643-1650.
Bernués M, Durán MA, Puget G, et al. Genetics of lymphocytes influences the emergence of second cancer in chronic lymphocytic leukemia. Anticancer Res. 2014;34(5):2311-2314.
Chaabouni H, Kacem K, Zriba S, et al. Solid tumors after chronic lymphocytic leukemia patients: Report of six cases and review of the literature. Gulf J Oncolog. 2015;1(19):28-32.
Leukemia & Lymphoma Society. Chronic lymphocytic leukemia: Disease Complications. Accessed at http://www.lls.org/leukemia/chronic-lymphocytic-leukemia/disease-complications on April 18, 2018.
National Cancer Institute. Chronic Lymphocytic Leukemia Treatment (PDQ®)–Health Professional Version. February 7, 2018. Accessed at www.cancer.gov/types/leukemia/hp/cll-treatment-pdq on April 18, 2018.